← Open Payments lookup

NPI 1003818147: Open Payments

NPI 1003818147. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$413 in 20 payments from 13 companies in 2025. Trend: 2023 $556 · 2024 $476 · 2025 $413

Food & beverage: $413
CompanyPaymentsAmount
UROGEN PHARMA, INC.4$111
TOLMAR, INC.3$56
Dendreon Pharmaceuticals LLC2$49
Sumitomo Pharma America, Inc.2$34
Procept Biorobotics Corporation1$24
Bayer Healthcare Pharmaceuticals Inc.1$21
Merck Sharp & Dohme LLC1$20
Ferring Pharmaceuticals Inc.1$19
Calyxo, Inc.1$17
Novartis Pharmaceuticals Corporation1$17

Products named: JELMYTO, PROVENGE, JATENZO, ZUSDURI, AQUABEAM ROBOTIC SYSTEM, Nubeqa, KEYTRUDA, GEMTESA.